Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

NCT00728845 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Lung Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: carboplatin
DRUG: hydroxychloroquine
DRUG: paclitaxel

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]